Literature DB >> 11961098

Loss of urate oxidase activity in hominoids and its evolutionary implications.

Masako Oda1, Yoko Satta, Osamu Takenaka, Naoyuki Takahata.   

Abstract

We have determined and compared the promoter, coding, and intronic sequences of the urate oxidase (Uox) gene of various primate species. Although we confirm the previous observation that the inactivation of the gene in the clade of the human and the great apes results from a single CGA to TGA nonsense mutation in exon 2, we find that the inactivation in the gibbon lineage results from an independent nonsense mutation at a different CGA codon in exon 2 or from either one-base deletion in exon 3 or one-base insertion in exon 5, contrary to the previous claim that the cause is a 13-bp deletion in exon 2. We also find that compared with other organisms, the primate functional Uox gene is exceptional in terms of usage of CGA codons which are prone to TGA nonsense mutations. Nevertheless, we demonstrate rather strong selective constraint against nonsynonymous sites of the functional Uox gene and argue that this observation is consistent with the fact that the Uox gene is unique in the genome and evolutionarily conserved not only among animals but also among eukaryotes. Another finding that there are a few substitutions in the cis-acting element or CAAT-box (or both) of primate functional Uox genes may explain the lowered transcriptional activity. We suggest that although the inactivation of the hominoid Uox gene was caused by independent nonsense or frameshift mutations, the gene has taken a two-step deterioration process, first in the promoter and second in the coding region during primate evolution. It is also argued that the high concentration of uric acid in the blood of humans and nonhuman primates has developed molecular coevolution with the xanthine oxidoreductase in purine metabolism. However, it remains to be answered whether loss of Uox activity in hominoids is related to protection from oxidative damage and the prolonged life span.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11961098     DOI: 10.1093/oxfordjournals.molbev.a004123

Source DB:  PubMed          Journal:  Mol Biol Evol        ISSN: 0737-4038            Impact factor:   16.240


  122 in total

1.  Selective pressure on the allantoicase gene during vertebrate evolution.

Authors:  Davide Vigetti; Giorgio Binelli; Claudio Monetti; Mariangela Prati; Giovanni Bernardini; Rosalba Gornati
Journal:  J Mol Evol       Date:  2003-12       Impact factor: 2.395

2.  Uric acid: a danger signal from the RNA world that may have a role in the epidemic of obesity, metabolic syndrome, and cardiorenal disease: evolutionary considerations.

Authors:  Richard J Johnson; Miguel A Lanaspa; Eric A Gaucher
Journal:  Semin Nephrol       Date:  2011-09       Impact factor: 5.299

3.  Allantoin as a vitamin.

Authors:  E P Gus'kov; V N Prokof'ev; M E Kletskii; I V Kornienko; O A Gapurenko; L P Olekhnovich; V A Chistyakov; A V Shestopalov; M A Sazykina; A V Markeev; T P Shkurat; S R Malkhos'yan; Yu A Zhdanov
Journal:  Dokl Biochem Biophys       Date:  2004 Sep-Oct       Impact factor: 0.788

4.  Linkage analysis with an interbreed backcross maps Dalmatian hyperuricosuria to CFA03.

Authors:  Noa Safra; Robert H Schaible; Danika L Bannasch
Journal:  Mamm Genome       Date:  2006-04-04       Impact factor: 2.957

Review 5.  The planetary biology of ascorbate and uric acid and their relationship with the epidemic of obesity and cardiovascular disease.

Authors:  Richard J Johnson; Eric A Gaucher; Yuri Y Sautin; George N Henderson; Alex J Angerhofer; Steven A Benner
Journal:  Med Hypotheses       Date:  2008-03-10       Impact factor: 1.538

6.  Uric acid: a modulator of prostate cells and activin sensitivity.

Authors:  Febbie Sangkop; Geeta Singh; Ely Rodrigues; Elspeth Gold; Andrew Bahn
Journal:  Mol Cell Biochem       Date:  2016-02-24       Impact factor: 3.396

7.  [Hyperuricemia and gout: diagnosis and therapy].

Authors:  A K Tausche; S Unger; K Richter; C Wunderlich; J Grässler; B Roch; H E Schröder
Journal:  Internist (Berl)       Date:  2006-05       Impact factor: 0.743

8.  Evolutionary history and metabolic insights of ancient mammalian uricases.

Authors:  James T Kratzer; Miguel A Lanaspa; Michael N Murphy; Christina Cicerchi; Christina L Graves; Peter A Tipton; Eric A Ortlund; Richard J Johnson; Eric A Gaucher
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-18       Impact factor: 11.205

Review 9.  Potential role of uric acid in metabolic syndrome, hypertension, kidney injury, and cardiovascular diseases: is it time for reappraisal?

Authors:  Zohreh Soltani; Kashaf Rasheed; Daniel R Kapusta; Efrain Reisin
Journal:  Curr Hypertens Rep       Date:  2013-06       Impact factor: 5.369

Review 10.  New insights on the risk for cardiovascular disease in African Americans: the role of added sugars.

Authors:  Karim R Saab; Jessica Kendrick; Joseph M Yracheta; Miguel A Lanaspa; Maisha Pollard; Richard J Johnson
Journal:  J Am Soc Nephrol       Date:  2014-08-04       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.